Baird Capital Invests in Azzur Group

Today, Baird Capital's private equity team announced its investment in Azzur Group ("Azzur"), one of the nation's fastest-growing life science consultancies. The investment aims to help Azzur accelerate expanding its professional services to the industry, including Azzur Cleanrooms on Demand^TM.

In partnering with Baird Capital, Azzur further solidifies its commitment to serving the life science and healthcare industries through the delivery of novel services designed to accelerate therapeutic delivery timelines and empower innovators to start, scale, and sustain their GxP organizations.

“Baird Capital has a history of investing in pharma services businesses, and we look forward to bringing our resources, relationships, and experiences to support Azzur’s future growth,” said Brett Tucker, Partner with Baird Capital’s private equity team. “We are excited to partner with Michael and his strong leadership team to help them build on their past successes.”

Baird Capital’s private equity team recently published a piece outlining their views on the broader outsourced pharma services market. Learn why they see the sector as a compelling investment destination and get the team’s views on subsectors with unique growth opportunities.

To learn more about the Azzur investment, click here.